Recent advances in pediatric renal neoplasia

Advances in Anatomic Pathology

Volumn 10, Issue 5, 2003, Pages 243-260

  Argani, Pedram ^a   Ladanyi, Marc ^b  

^a JOHNS HOPKINS HOSPITAL   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Congenital mesoblastic nephroma; Kidney; Primitive neuroectodermal tumor; Rhabdoid tumor; Synovial sarcoma; Translocation carcinoma

Indexed keywords

DNA;

ADOLESCENT; CHILD; CLEAR CELL SARCOMA; GENE TRANSLOCATION; GENETICS; HUMAN; KIDNEY CARCINOMA; KIDNEY TUMOR; MESOBLASTIC NEPHROMA; PATHOLOGY; REVIEW; RHABDOID TUMOR;

ADOLESCENT; CARCINOMA, RENAL CELL; CHILD; DNA, NEOPLASM; HUMANS; KIDNEY NEOPLASMS; NEPHROMA, MESOBLASTIC; RHABDOID TUMOR; SARCOMA, CLEAR CELL; TRANSLOCATION, GENETIC;

EID: 2142769869     PISSN: 10724109     EISSN: 15334031     Source Type: Journal    
DOI: 10.1097/00125480-200309000-00001     Document Type: Review

References (92)

1. Beckwith JB. Renal neoplasms of childhood. In: Sternberg SS, ed. Diagnostic Surgical Pathology. 3rd ed. Philadelphia, PA: Lippincott Williams &Wilkins; 1999:1825-1852.
2. Beckwith JB. Renal tumors. In: Stocker JT, Askin FB. Pathology of Solid Tumors in Children. London: Chapman and Hall Medical;1998:1-23.
3. Beckwith JB. National Wilms tumor study: an update for pathologists. Pediatr Dev Pathol. 1998;1:79-84. (Pubitemid 128542115)
4. Green DM, Coppes MJ, Breslow NE, et al. Wilms tumor. In: Pizzo PA, Poplack DG, eds. Principles and Practice of Pediatric Oncology. 3rd ed. Philadelphia, PA: Lippincott-Raven; 1997:733-759.
5. Green DM, Breslow NE, Beckwith JB, et al. Treatment of children with clear-cell sarcoma of the kidney: a report from the National Wilms' Tumor Study Group. J Clin Oncol. 1994;12:2132-2137. (Pubitemid 24356031)
6. Argani P, Perlman EJ, Breslow NE, et al. Clear cell sarcoma of the kidney: a review of 351 cases from the National Wilms Tumor Study Group Pathology Center. Am J Surg Pathol. 2000;24:4-18. (Pubitemid 30033392)
7. Weeks DA, Beckwith JB, Mierau GW, et al. Rhabdoid tumor of kidney: a report of 111 cases from the National Wilms' Tumor Study pathology center. Am J Surg Pathol. 1989;13:439-458. (Pubitemid 19149607)
8. Renshaw AA, Granter SR, Fletcher JA, et al. Renal cell carcinomas in children and young adults: increased incidence of papillary architecture and unique subtypes. Am J Surg Pathol. 1999;23:795-802. (Pubitemid 29307685)
9. Bolande RP, Brough AJ, Izant RJ. Congenital mesoblastic nephroma of infancy. Pediatrics. 1967;40:272-279.
10. Howell CG, Othersen HB, Kiviat NE, et al. Therapy and outcome in 51 children with mesoblastic nephroma: a report of the National Wilms Tumor Study. J Ped Surgery. 1982;17:826-831. (Pubitemid 13181161)
11. Beckwith JB. Tumors of infancy and childhood. In: Murphy WM, Beckwith JB, Farrow GM, eds. Tumors of the Kidney, Bladder, and Related Urinary Structures: Atlas of Tumor Pathology. 3rd series, Fascicle 11. Washington DC: Armed Forces Institute of Pathology; 1994:12-91.
12. Argani P, Fritsch M, Kadkol SS, et al. Detection of the ETV6-NTRK3 chimeric RNA of infantile fibrosarcoma/cellular congenital mesoblastic nephroma in paraffin-embedded tissue: application to challenging pediatric renal stromal tumors. Mod Pathol. 2000;13:29-36. (Pubitemid 30077901)
13. Argani P, Beckwith JB. Metanephric stromal tumor: Report of 31 cases of a distinctive pediatric renal neoplasm. Am J Surg Pathol. 2000;24:917-926. (Pubitemid 30430479)
14. Arroyo MR, Green DM, Perlman EJ, et al. The spectrum of metanephric adenofibroma and related lesions. Clinicopathologic study of 25 cases from the National Wilms Tumor Pathology Center. Am J Surg Pathol. 2001;24:433-444. (Pubitemid 32240882)
15. Hennigar RA, Beckwith JB. Nephrogenic adenofibroma. A novel kidney tumor of young people. Am J Surg Pathol. 1992;16:325-334.
16. Coffin CM, Jaszcz W, O'Shea PA, et al. So-called congenital-infantile fibrosarcoma: does it exist and what is it? Pediatr Pathol. 1994;14:133-150. (Pubitemid 24034190)
17. Stout AP. Fibrosarcoma in infants and children. Cancer. 1962;15:1028-1040.
18. Schofield DE, Yunis EJ, Fletcher JA. Chromosome aberrations in mesoblastic nephroma. Am J Pathol. 1993;143:714-724. (Pubitemid 24058228)
19. Mascarello JT, Cajulis TR, Krous HF, et al. Presence or absence of trisomy 11 is correlated with histologic subtype in congenital mesoblastic nephroma. Cancer Genet Cytogenet. 1994;77:50-54. (Pubitemid 24334431)
20. Pettinato G, Manivel JC, Wick MR, et al. Classical and cellular (atypical) congenital mesoblastic nephroma: a clinicopathologic, ultrastructural, immunohistochemical, and flow cytometric study. Hum Pathol. 1989;20:682-690. (Pubitemid 19185298)
21. Knezevich SR, McFadden DE, Tao W, et al. A novel ETV6-NTRK3 gene fusion in congenital fibrosarcoma. Nat Genet. 1998;18:184-187. (Pubitemid 28082471)
22. Golub TR, Barker GF, Bohlander SK, et al. Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia. Proc Natl Acad Sci. 1995;92:4917-4921.
23. Knezevich SR, Garnett MJ, Pysher TJ, et al. ETV6-NTRK3 gene fusions and trisomy 11 establish a histogenetic link between mesoblastic nephroma and congenital fibrosarcoma. Cancer Res. 1998;58:5046-5048. (Pubitemid 28521157)
24. Rubin BP, Chen CJ, Morgan TW, et al. Congenital mesoblastic nephroma t(12;15) is associated with ETV6-NTRK3 gene fusion: cytogenetic and molecular relationship to congenital (infantile) fibrosarcoma. Am J Pathol. 1998;153:1451-1458. (Pubitemid 28509901)
25. Wai DH, Knezevich SR, Lucas T, et al. The ETV6-NTRK3 gene fusion encodes a chimeric protein tyrosine kinase that transforms NIH3T3 cells. Oncogene. 2000;19:906-915. (Pubitemid 30153748)
26. Tognon C, Garnett M, Kenward E, et al. The chimeric protein tyrosine kinase ETV6-NTRK3 requires both Ras-Erk1/2 and PI3-Kinase-Akt signaling for fibroblast transformation. Cancer Res. 2001;61:8909-8916. (Pubitemid 34013908)
27. Beckwith JB, Palmer NF. Histopathology and prognosis of Wilms tumor: results from the first National Wilms tumor study. Cancer . 1978;41:1937-1948. (Pubitemid 8335406)
28. Bonnin JM, Rubinstein LJ, Palmer NF, et al. The association of embryonal tumors originating in the kidney and in the brain: a report of seven cases. Cancer. 1984;54:2137-2146. (Pubitemid 15210797)
29. Weeks DA, Beckwith JB, Mierau GW, et al. Renal neoplasms mimicking rhabdoid tumor of kidney: a report from the National Wilms' Tumor Study pathology center. Am J Surg Pathol. 1991;15:1042-1054.
30. Gökden N, Nappi O, Swanson PE, et al. Renal cell carcinoma with rhabdoid features. Am J Surg Pathol. 2000;24:1329-1338.
31. Guillou L, Wadden C, Coindre JM, et al. Proximal-type epithelioid sarcoma, a distinctive aggressive neoplasm showing rhabdoid features. Clinicopathologic, immunohistochemical, and ultrastructural study of a series. Am J Surg Pathol. 1997;21:130-146. (Pubitemid 27084052)
32. Parham DM, Weeks DA, Beckwith JB. The clinicopathologic spectrum of putative extrarenal rhabdoid tumors. Am J Surg Pathol. 1994;18:1010-1029.
33. Davis CJ, Mostofi FK, Sesterhenn IA. Renal medullary carcinoma: the seventh sickle cell nephropathy. Am J Surg Pathol. 1995;19:1-11.
34. Amin MB, Varma MD, Tickoo SK, et al. Collecting duct carcinoma of the kidney. Adv Anat Pathol. 1997;4:85-94.
35. Srigley JR, Eble JN. Collecting duct carcinoma of the kidney. Semin Diagn Pathol. 1998;15:54-67.
36. Versteege I, Sevenet N, Lange J, et al. Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer. Nature. 1998;394:203-206. (Pubitemid 28325977)
37. Biegel JA, Zhou JY, Rorke LB, et al. Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors. Cancer Res. 1999;59:74-79. (Pubitemid 29062960)
38. Sevenet N, Sheridan E, Amram D, et al. Constitutional mutations of the hSNF5/INI1 gene predispose to a variety of cancers. Am J Hum Genet. 1999;65:1342-1348. (Pubitemid 30460384)
39. Taylor MD, Gokgoz N, Andrulis IL, et al. Familial posterior fossa brain tumors of infancy secondary to germline mutation of the hSNF5 gene. Am J Hum Genet. 2000;66:1403-1406. (Pubitemid 30468794)
40. Burger PC, Yu I-T, Tihan T, et al. Atypical teratoid/rhabdoid tumor of the central nervous system: a highly malignant tumor of infancy and childhood frequently mistaken for medulloblastoma. A pediatric oncology group study. Am J Surg Pathol. 1998;22:1083-1092. (Pubitemid 28411066)
41. Fort DW, Tonk VS, Tomlinson GE, et al. Rhabdoid tumor of the kidney with primitive neuroectodermal tumor of the central nervous system: associated findings with different histologic, cytogenetic, and molecular findings. Genes, Chromosomes & Cancer. 1994;11:146-152. (Pubitemid 24333389)
42. Savla J, Chen TT-Y, Schneider N, et al. Mutations of the hSNF5/INI1 gene in renal rhabdoid tumors with secondary brain tumors. J Natl Cancer Institute. 2000;92:648-650. (Pubitemid 30321308)
43. Biegel JA, Fogelgren B, Wainwright LM, et al. Germline INI1 mutation in a patient with a central nervous system atypical teratoid tumor and renal rhabdoid tumor. Genes, Chromosomes & Cancer. 2000;28:31-37. (Pubitemid 30176760)
44. Delahunt B, Beckwith JB, Eble JN, et al. Cystic embryonal sarcoma of kidney: a case report. Cancer. 1998;82:2427-2433. (Pubitemid 28283450)
45. Argani P, Faria PA, Epstein JI, et al. Primary renal synovial sarcoma. Morphologic and molecular delineation of an entity previously included among embryonal sarcomas of the kidney. Am J Surg Pathol. 2000;24:1087-1096. (Pubitemid 30612830)
46. Kim D-W, Sohn JH, Lee MC, et al. Primary synovial sarcoma of the kidney. Am J Surg Pathol. 2000;24:1097-1104. (Pubitemid 30612831)
47. Jun SY, Choi J, Kang GH, et al. Synovial sarcoma (SS) of the kidney with rhabdoid (R) features. Mod Pathol. 2003;16:155A.
48. Quezado M, Benjamin DR, Tsokos M. EWS/FLI-1 fusion transcripts in three peripheral primitive neuroectodermal tumors of the kidney. Hum Pathol. 1997;28:767-771. (Pubitemid 27298959)
49. Marley EF, Liapis H, Humphrey PA, et al. Primitive neuroectodermal tumor of the kidney-Another enigma: a pathologic, immunohistochemical, and molecular diagnostic study. Am J Surg Pathol. 1997;21:354-359. (Pubitemid 27120206)
50. Furman J, Murphy WM, Jelsma PF, et al. Primary primitive neuroectodermal tumor of the kidney. Case report and review of the literature. Am J Clin Pathol. 1996;106:339-344. (Pubitemid 26309086)
51. Takeuchi T, Iwasaki H, Ohjimi Y, et al. Renal primitive neuroectodermal tumor: a morphologic, cytogenetic, and molecular analysis with the establishment of two cultured cell lines. Diagn Molec Pathol. 1997;6:309-317. (Pubitemid 28175930)
52. O'Sullivan MJ, Perlman EJ, Furman J, et al. Visceral primitive peripheral neuroectodermal tumors: a clinicopathologic and molecular study. Hum Pathol. 2001;32:1109-1115. (Pubitemid 33015672)
53. Casella R, Moch H, Rochlitz C, et al. Metastatic primitive neuroectodermal tumor of the kidney in adults. Eur Urol. 2001;39:613-617. (Pubitemid 32678982)
54. Sheaff M, McManus A, Scheimberg I, et al. Primitive neuroectodermal tumor of the kidney confirmed by fluorescence in situ hybridization. Am J Surg Pathol. 197;21:461-468.
55. Karnes RJ, Gettman MT, Anderson PM. Primitive neuroectodermal tumor (extraskeletal Ewing's sarcoma) of the kidney with vena caval thrombus. J Urol. 2000;164:772. (Pubitemid 30637622)
56. Segura A, Perez J, Reynes GZ, et al. Primitive neuroectodermal kidney tumor. Med Pediatr Oncol. 2002;38:145.
57. Rodriguez-Galindo C, Marina NM, Fletcher BD, et al. Is primitive neuroectodermal tumor of the kidney a distinct entity? Cancer. 1997;79:2243-2250. (Pubitemid 27227391)
58. Herman TE, McAlister WH, Dehner LP. Peripheral primitive neuroectodermal timor: report of a case arising in the kidney. Pediatr Radiol. 1997; 27:620-621. (Pubitemid 27303528)
59. Kuroda M, Urano M, Abe M, et al. Primary primitive neuroectodermal tumor of the kidney. Pathol Int. 2000;50:967-972. (Pubitemid 32128473)
60. Jimenez RE, Folpe AL, Lapham RL, et al. Primary Ewing's sarcoma/Primitive neuroectodermal tumor of the kidney. A clinicopathologic and immunohistochemical analysis of 11 cases. Am J Surg Pathol. 2002;26:320-327. (Pubitemid 34184455)
61. Gu M, Antonescu CR, Guiter G, et al. Cytokeratin immunoreactivity in Ewing's sarcoma: prevalence in 50 cases confirmed by molecular diagnostic studies. Am J Surg Pathol. 2000;24:410-416. (Pubitemid 30127477)
62. de Alava E, Kawai A, Healey JH, et al. EWS-FLI1 fusion transcript structure is an independent determinant of prognosis in Ewing's sarcoma. J Clin Oncol. 1998;16:1248-1255. (Pubitemid 28175736)
63. Zoubek A, Dockhorn-Dwornicziak B, Dellatre O, et al. Does expression of different EWS chimeric transcripts define clinically distinct groups of Ewing tumor patients? J Clin Oncol. 1996;14:1245-1251. (Pubitemid 26105532)
64. Parham DM, Roloson GJ, Feely M. et al. Primary malignant neuroepithelial tumors of the kidney. A clinicopathologic analysis of 146 adult and pediatric cases from the National Wilms Tumor Study Group Pathology Center. Am J Surg Pathol. 2001;25:133-146. (Pubitemid 32167495)
65. Sidhar SK, Clark J, Gill S, et al. The t(X;1) (p11.2;q21.2) translocation in papillary renal cell carcinoma fuses a novel gene PRCC to the TFE3 transcription factor gene. Hum Mol Genet. 1996;5:1333-1338. (Pubitemid 26335852)
66. Weterman MAJ, Wilbrink M, Geurts van Kessel A. Fusion of the transcription factor TFE3 gene to a novel gene, PRCC, in t(X;1)(p11.2;q21)- positive papillary renal cell carcinomas. Proc Natl Acad Sci U S A. 1996; 93:15294-15298.
67. Clark J, Lu Y-J, Sidhar SK, et al. Fusion of splicing factor genes PSF and NonO (p54nrb) to the TFE3 gene in papillary renal cell carcinoma. Oncogene. 1997;15:2233-2239. (Pubitemid 27493913)
68. Hernandez-Marti MJ, Orellana-Alonso C, Badia-Garrabou L, et al. Renal adenocarcinoma in an 8-year-old child, with a t(X;17)(p11.2;q25). Cancer Genet Cytogenet. 1995;83:82-83.
69. Carcao MD, Taylor GP, Greenberg ML, et al. Renal cell carcinoma in children. A different disorder from its adult counterpart? Med Pediatr Oncol. 1998;31:153-158. (Pubitemid 28387912)
70. Heimann P, Devalck C, Debusscher C, et al. Alveolar soft-part sarcoma. Further evidence by FISH for the involvement of chromosome band 17q25. Genes. Chromosomes Cancer. 1998;23:194-197. (Pubitemid 28402347)
71. Tomlinson GE, Nisen PD, Timmons CF, et al. Cytogenetics of a renal cell carcinoma in a 17-month-old child. Evidence for Xp11.2 as a recurring breakpoint. Cancer Genet Cytogenet. 1991;57:11-17.
72. Ladanyi M, Lui MY, Antonescu CR, et al. The der(17)t(X;17)(p11;q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25. Oncogene. 2001;20:48-57. (Pubitemid 32142337)
73. Argani P, Antonescu CR, Illei PB, et al. Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma.Adistinctive tumor entity previously included among renal cell carcinomas of children and adolescents. Am J Pathol. 2001;159:179-192. (Pubitemid 33704203)
74. Heimann P, El Housni H, Ogur G, et al. Fusion of a novel gene, RCC17, to the TFE3 gene in t(X;17)(p11.2;q25.3)-bearing papillary renal cell carcinomas. Cancer Res. 2001;61:4130-4135. (Pubitemid 32720981)
75. Argani P, Antonescu CR, Couturier J, et al. PRCC-TFE3 renal carcinomas. Morphologic, immunohistochemical, ultrastructural, and molecular analysis of an entity associated with the t(X;1)(p11.2;q21). Am J Surg Pathol. 2002;26:1553-1566. (Pubitemid 35387219)
76. Meloni AM, Dobbs RM, Pontes JE, et al. Translocation (X;1) in papillary renal cell carcinoma. A new cytogenetic subtype. Cancer Genet Cytogenet. 1993;65:1-6. (Pubitemid 23070699)
77. Perot C, Bougaran J, Boccon-Gibod L, et al. Two new cases of papillary renal cell carcinoma with t(X;1)(p11;q21) in females. Cancer Genet Cytogenet. 1999;110:54-56. (Pubitemid 29157810)
78. Argani P, Lal P, Hutchinson B, et al. Aberrant nuclear immunoreactivity for TFE3 in neoplasms with TFE3 gene fusions: a sensitive and specific immunohistochemical assay. Am J Surg Pathol. 2003;27:750-761. (Pubitemid 36617511)
79. Skalsky YM, Ajuh PM, Parker C, et al. PRCC, the commonest TFE3 fusion partner in papillary renal carcinoma is associated with pre-mRNA splicing factors. Oncogene. 2001;20:178-187. (Pubitemid 32150263)
80. Weterman MAJ, von Groningen JJM, Jansen A, et al. Nuclear localization and transactivating capacities of the papillary renal cell carcinomaassociated TFE3 and PRCC (fusion) proteins. Oncogene. 2000;19:69-74. (Pubitemid 30066352)
81. Weterman MAJ, van Groningen JJ, Tertoolen L, et al. Impairment of MAD2B-PRCC interaction in mitotic checkpoint defective t(X;1)-positive renal cell carcinomas. Proc Natl Acad Sci U S A. 2001;98:13808-13813. (Pubitemid 33115980)
82. Argani P, Lui MY, Couturier J, et al. Cloning of a novel CLTC-TFE3 gene fusion in pediatric renal adenocarcinoma with t(X;17)(p11.2;q23). Oncogene, in press.
83. Bridge JA, Kanamori M, Ma Z, et al. Fusion of the ALK gene to the Clathrin Heavy Chain Gene, CLTC, in Inflammatory myofibroblastic tumor. Am J Pathol. 2001;159:411-415. (Pubitemid 32751070)
84. Touriol C, Greenland C, Lament L, et al. Further demonstration of the diversity of chromosomal changes involving 2p23 in ALK-positive lymphoma: 2 cases expressing ALK kinase fused to CLTCL (clathrin chain polypeptide-like). Blood. 2000;95:3204-3207. (Pubitemid 30321174)
85. Dijkhuizen T, van den Berg E, Storkel S, et al. Two cases of renal cell carcinoma, clear cell type, revealing a t(6;11)(p21;q13) (abstract). Cancer Genet Cytogenet. 1996;91:141.
86. Argani P, Hawkins A, Griffin CA, et al. A distinctive pediatric renal neoplasm characterized by epithelioid morphology, basement membrane production, focal HMB45 immunoreactivity, and t(6; 11)(p21.1; q12) chromosome translocation. Am J Pathol. 2001;158:2089-2096. (Pubitemid 32545194)
87. Yeh Y, Vargas S, Fletcher JA, et al. Distinctive chromosomal translocations in pediatric renal cell carcinoma (abstract). Mod Pathol . 2002;15:7P.
88. Davis IJ, His B-L, Arroyo JD, et al. Cloning of a novel Alpha-TFEB fusion in renal tumors harboring the t(6;11)(p21;q12) chromosome translocation. Proc Natl Acad Sci U S A. 2003;100:6051-6056. (Pubitemid 36576929)
89. Chang KL, Folpe AL. Diagnostic utility of microphthalmia transcription factor in malignant melanoma and other tumors. Adv Anat Pathol. 2001;8:273-275.
90. Hemesath TJ, Steingrimsson E, McGill G, et al. Microphthalmia, a critical factor in melanocytic development, defines a discrete transcription factor family. Genes & Development. 1994;8:2770-2780. (Pubitemid 24375425)
91. Steingrimsson E, Tessarollo L, Reid SW, et al. The bHLH-Zip transcription factor Tfeb is essential for placental vascularization. Development. 1998;125:4607-4616. (Pubitemid 29027191)
92. Fisher DE, Carr CS, Parent LA, et al. TFEB has DNA-binding and oligomerization properties of a unique helix-loop-helix/leucine-zipper family. GenesDev. 1991;5:2342-2352. (Pubitemid 21905922)